I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Randomized, open-label, phase 2 study of andecaliximab plus..:
Shah, Manish A
;
Cunningham, David
;
Metges, Jean-Philippe
...
Journal for ImmunoTherapy of Cancer. 9 (2021) 12 - p. e003580 , 2021
Link:
https://doi.org/10.1136/jitc-2021-003580
RT Journal T1
Randomized, open-label, phase 2 study of andecaliximab plus nivolumab versus nivolumab alone in advanced gastric cancer identifies biomarkers associated with survival
UL https://suche.suub.uni-bremen.de/peid=cr-10.1136_jitc-2021-003580&Exemplar=1&LAN=DE A1 Shah, Manish A A1 Cunningham, David A1 Metges, Jean-Philippe A1 Van Cutsem, Eric A1 Wainberg, Zev A1 Elboudwarej, Emon A1 Lin, Kai-Wen A1 Turner, Scott A1 Zavodovskaya, Marianna A1 Inzunza, David A1 Liu, Jinfeng A1 Patterson, Scott D A1 Zhou, Jingzhu A1 He, Jing A1 Thai, Dung A1 Bhargava, Pankaj A1 Brachmann, Carrie Baker A1 Cantenacci, Daniel V T PB BMJ YR 2021 SN 2051-1426 JF Journal for ImmunoTherapy of Cancer VO 9 IS 12 SP e003580 LK http://dx.doi.org/https://doi.org/10.1136/jitc-2021-003580 DO https://doi.org/10.1136/jitc-2021-003580 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)